Rosa Lapalombella, PhD
College of Medicine
>Leukemia, Lymphocytic, Chronic, B-Cell ● Cancer ● Lymphoma, Mantle-Cell ● Glioblastoma ● Ischemia ● Lymphoma
Rosa Lapalombella, PhD, is a member of the Leukemia Research Program at the OSUCCC – James, where she focuses her research on epigenetic alterations of cancer cells and the development of experimental therapeutics for hematologic disease. She is the co-holder of a patent for methods and compositions for delivering therapeutic agents in the treatment of B-cell-related disorders.Dr. Lapalombella’s work has contributed to the translation of five therapeutic agents into clinical trials for chronic lymphocytic leukemia (CLL). Her work has been reported in more than 40 articles that have been published in academic journals, including Cancer Discovery, Cancer Cell, Journal of Clinical Oncology, Leukemia and Blood. In addition to publications, her work has been recognized with many oral presentations at national and international conferences including the American Society of Hematology, Italian Society of Biology and Genetics, and Translational Research Cancer Centers Consortium. Dr. Lapalombella has been the recipient of the Department of Defense Career Development Award for young faculty and the American Cancer Society Research Scholar Award. Her experience includes more than 10 grant-funded research initiatives. Additionally, she is the associate director for basic research in the Division of Hematology and also serves as the director of the Pelotonia Fellowship Program, overseeing the peer-review process used to evaluate all student applications for Pelotonia fellowships and identifying those with the highest scientific merit for funding.
BA, University of Bologna, Italy
410 W 12th Ave, Columbus, OH 43210